共 43 条
[1]
Schold, Friedman, Bjornsson, Falleta, Treatment of patients with recurrent primary brain tumors with AZQ, Neurology, 34, pp. 615-619, (1984)
[2]
Lee, Van Echo, Egorin, Nayar, Shulman, Schiffer, Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocyticleukemia, Blood, 67, pp. 182-187, (1986)
[3]
Schulman, Davis, Lee, Ellerton, Staszweski, Phase II study of continuous-infusion diaziquone in relapsed/refractory acute nonlymphocytic leukemia, Cancer Treat. Rep., 71, pp. 755-757, (1987)
[4]
Mossoba, Alizadeh, Gutierrez, mechanism for the reductive activation of diaziquone, J. Pharm. Sci., 74, pp. 1249-1254, (1985)
[5]
Szmigiero, Kohn, Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (Diaziquone) in isolated nuclei from human cells, Cancer Res., 44, pp. 4453-4457, (1984)
[6]
Gutierrez, Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ), Free Radic. Biol. Med., 6, pp. 405-445, (1989)
[7]
Sinha, Katki, Batist, Cowan, Myers, Differential formation of hydroxyl radicals by Adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action, Biochemistry, 26, pp. 3776-3781, (1987)
[8]
Ernster, DT diaphorase: a historical review, Chemica Scripta, 27 A, pp. 1-13, (1987)
[9]
Buffinton, Ollinger, Brunmark, Cadenas, DT-diaphorase-catalysed reduction of 1,4-naphthoquinone derivatives and glutathionyl-quinone conjugates, Biochem. J., 257, pp. 561-571, (1989)
[10]
Ernster, DT diaphorase, Methods in enzymology, pp. 309-317, (1967)